IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v525y2015i7570d10.1038_nature14898.html
   My bibliography  Save this article

Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

Author

Listed:
  • Philipp Rathert

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Mareike Roth

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Tobias Neumann

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Felix Muerdter

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Jae-Seok Roe

    (Cold Spring Harbor Laboratory)

  • Matthias Muhar

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Sumit Deswal

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Sabine Cerny-Reiterer

    (Medical University of Vienna
    Ludwig Boltzmann Cluster Oncology, Medical University of Vienna)

  • Barbara Peter

    (Medical University of Vienna
    Ludwig Boltzmann Cluster Oncology, Medical University of Vienna)

  • Julian Jude

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Thomas Hoffmann

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Łukasz M. Boryń

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Elin Axelsson

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Norbert Schweifer

    (Boehringer Ingelheim – Regional Center Vienna GmbH)

  • Ulrike Tontsch-Grunt

    (Boehringer Ingelheim – Regional Center Vienna GmbH)

  • Lukas E. Dow

    (Hematology & Medical Oncology, Weill Cornell Medical College)

  • Davide Gianni

    (Boehringer Ingelheim – Regional Center Vienna GmbH)

  • Mark Pearson

    (Boehringer Ingelheim – Regional Center Vienna GmbH)

  • Peter Valent

    (Medical University of Vienna
    Ludwig Boltzmann Cluster Oncology, Medical University of Vienna)

  • Alexander Stark

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

  • Norbert Kraut

    (Boehringer Ingelheim – Regional Center Vienna GmbH)

  • Christopher R. Vakoc

    (Cold Spring Harbor Laboratory)

  • Johannes Zuber

    (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC))

Abstract

BET bromodomain inhibitors are being explored as potential therapeutics in cancer; here, AML cells are shown to evade sensitivity to BET inhibition through rewiring the transcriptional regulation of BRD4 target genes such as MYC in a process that is facilitated by suppression of PRC2 and WNT signalling activation.

Suggested Citation

  • Philipp Rathert & Mareike Roth & Tobias Neumann & Felix Muerdter & Jae-Seok Roe & Matthias Muhar & Sumit Deswal & Sabine Cerny-Reiterer & Barbara Peter & Julian Jude & Thomas Hoffmann & Łukasz M. Bory, 2015. "Transcriptional plasticity promotes primary and acquired resistance to BET inhibition," Nature, Nature, vol. 525(7570), pages 543-547, September.
    • Handle: RePEc:nat:nature:v:525:y:2015:i:7570:d:10.1038_nature14898
    DOI: 10.1038/nature14898
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature14898
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature14898?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jeannine Diesch & Marguerite-Marie Le Pannérer & René Winkler & Raquel Casquero & Matthias Muhar & Mark van der Garde & Michael Maher & Carolina Martínez Herráez & Joan J. Bech-Serra & Michaela Fellne, 2021. "Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis," Nature Communications, Nature, vol. 12(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:525:y:2015:i:7570:d:10.1038_nature14898. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.